retatrutide new england journal of medicine Phase 2 Trial for Obesity Retatrutide: What It Is &

Importantly, the GLP-1R-cholesterol binding sites identified here do not overlap with previously predicted cholesterol consensus motifs (CCM) (22) or Cholesterol Recognition Amino Acid Consensus (CRAC) motifs (52) identified for other GPCRs, confirming the theory that GPCRs lack predictable primary sequence consensus motifs for cholesterol binding (53, 54)

It's glucagon doing exactly what glucagon does

For example, they might use 2.4 mg for 12 weeks, then reduce to 1.0 mg for 4 weeks, then return to 2.4 mg

E.JansonJ.Bonner-WeirS.RitzelR.RizzaR

Quesada BM, Kohan G, Roff HE, Canulln CM, Chiappetta Porras LT

The test identifies predispositions in GLP1R, GIPR, FTO, and MC4R genetic variants that may influence appetite regulation and metabolic response